{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:59:11Z","timestamp":1791950351670,"version":"4.3.4"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["\u00a0"],"award-info":[{"award-number":["\u00a0"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institute of Health","doi-asserted-by":"publisher","award":["UL1TR001878"],"award-info":[{"award-number":["UL1TR001878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe perinatal stress induced hyperinsulinism (PSIHI), determine the prevalence of neurodevelopmental differences, and identify risk factors for poor developmental prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Subjects with a history of hyperinsulinism (HI) and perinatal stress and in whom resolution of the HI was demonstrated were included. Medical record review, caregiver interview, and three validated developmental assessments were completed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 107 subjects (75% male), 36% were born between 32 and 37 weeks. Median age of hypoglycemia presentation was 0 days. Median age at HI diagnosis was 12 days (IQR 13.5). Median length of time for initiation of definitive treatment was 14 days (IQR 14).<\/jats:p>\n                    <jats:p>\n                      Caregiver interviews were completed for 53 of 79 eligible subjects. Developmental concerns were reported by 51%. Neurodevelopmental assessments were completed by caregivers of 37 of the 53 enrolled subjects. The proportion of subjects scoring &amp;gt;1 SD and &amp;gt;2 SD away from the mean in the direction of concern on the major composite scores was significantly greater than in the general population (40.5% vs. 15.8%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u20090.0001 and 18.9% vs. 2.2%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009\u2264\u20090.0001, respectively).\n                    <\/jats:p>\n                    <jats:p>\n                      Male sex, small for gestational age status (SGA), and treatment with continuous feeds were associated with assessment scores &amp;gt;1 SD from the mean (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05). SGA and preeclampsia were associated with assessment scores &amp;gt;2 SD from the mean (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While the majority of infants presented with hypoglycemia in the first day of life, diagnosis and treatment occurred 12\u201314 days later. Children with PSIHI are at high risk of neurodevelopmental deficits and are more likely to perform below average on developmental assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2022.999274","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T02:14:16Z","timestamp":1667182456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Natural history and neurodevelopmental outcomes in perinatal stress induced hyperinsulinism"],"prefix":"10.3389","volume":"10","author":[{"given":"Winnie M.","family":"Sigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohoud","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela M.","family":"Guadalupe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herodes","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerilynn","family":"Radcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas F.","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva D.","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0031-3955(05)70481-8","article-title":"Hyperinsulinism in infants and children","volume":"44","author":"Stanley","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk","volume":"161","author":"Harris","year":"2012","journal-title":"J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2013.00060","article-title":"Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism","volume":"4","author":"Avatapalle","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1515\/jpem-2019-0066","article-title":"Characterization of the duration of treatment with diazoxide in infants with prolonged hyperinsulinism (PHI)","volume":"32","author":"Raisingani","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"580642","DOI":"10.3389\/fendo.2020.580642","article-title":"Risk factors for adverse neurodevelopment in transient or persistent congenital hyperinsulinism","volume":"11","author":"Roeper","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2005.10.002","article-title":"Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism","volume":"148","author":"Hoe","year":"2006","journal-title":"J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1542\/peds.107.3.476","article-title":"Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia","volume":"107","author":"Menni","year":"2001","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000481774","article-title":"Formal neurocognitive testing in 60 patients with congenital hyperinsulinism","volume":"89","author":"Ludwig","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2015.09.045","article-title":"Biomarkers of insulin for the diagnosis of hyperinsulinemic hypoglycemia in infants and children","volume":"168","author":"Ferrara","year":"2016","journal-title":"J Pediatr"},{"key":"B11","volume-title":"ABAS, adaptive behavior assessment system: Manual","author":"Harrison","year":"2000"},{"key":"B12","volume-title":"Manual for the ASEBA preschool forms & profiles: An integrated system of multi-informant assessment","author":"Achenbach","year":"2000"},{"key":"B13","volume-title":". behavior rating inventory of executive function\u2014preschool version professional manual","author":"Gioia","year":"2003"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management","volume":"166","author":"Stanley","year":"2015","journal-title":"J Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endocr\/bqab121","article-title":"Decreased KATP channel activity contributes to the low glucose threshold for insulin secretion of rat neonatal islets","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pedn.2004.12.009","article-title":"Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism","volume":"20","author":"Steinkrauss","year":"2005","journal-title":"J Pediatr Nurs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00431-018-3242-7","article-title":"Transient neonatal hyperinsulinaemic hypoglycaemia: perinatal predictors of length and cost of stay","volume":"177","author":"Kozen","year":"2018","journal-title":"Eur J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2020.02.079","article-title":"Glucose profiles in healthy term infants in the first 5 days: the glucose in well babies (GLOW) study","volume":"223","author":"Harris","year":"2020","journal-title":"J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1530\/eje.0.1490043","article-title":"Long-term follow up of 114 patients with congenital hyperinsulinism","volume":"149","author":"Meissner","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0065-3101(22)00724-1","article-title":"Hyperinsulinism in infants and children: diagnosis and therapy","volume":"23","author":"Stanley","year":"1976","journal-title":"Adv Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpeds.2015.10.066","article-title":"Outcome at 2 years after dextrose gel treatment for neonatal hypoglycemia: follow-up of a randomized trial","volume":"170","author":"Harris","year":"2016","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years","volume":"373","author":"McKinlay","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.999274\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:24:22Z","timestamp":1678451062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.999274\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":23,"alternative-id":["10.3389\/fped.2022.999274"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.999274","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"999274"}}